calendar
6,562 catalysts · 3,603 8k filing · 1,000 device adverse event · 775 grant · 578 earnings · 234 approval · 172 phase 2 completion
next 91 dayslessmore
MonWedFri
6,562 catalysts · 3,603 8k filing · 1,000 device adverse event · 775 grant · 578 earnings · 234 approval · 172 phase 2 completion
Status: Current. Reason: not specified. Form: Injection
Status: Current. Reason: not specified. Form: Injection
Status: Current. Reason: not specified. Form: Injection
Status: Current. Reason: not specified. Form: Injection
Status: Current. Reason: not specified. Form: Injection
Status: Current. Reason: not specified. Form: Injection
Status: Current. Reason: not specified. Form: Injection
Status: Current. Reason: not specified. Form: Injection
Status: Current. Reason: not specified. Form: Injection
Status: Current. Reason: not specified. Form: Injection
Status: Current. Reason: not specified. Form: Injection
Status: Current. Reason: not specified. Form: Injection
Status: Current. Reason: not specified. Form: Injection
Status: Current. Reason: not specified. Form: Injection
Status: Current. Reason: not specified. Form: Injection
Status: Current. Reason: not specified. Form: Injection
Status: Current. Reason: not specified. Form: Injection
Status: Current. Reason: not specified. Form: Injection
Status: Current. Reason: not specified. Form: Injection
Status: Current. Reason: not specified. Form: Injection
Status: To Be Discontinued. Reason: not specified. Form: Capsule
Status: Current. Reason: not specified. Form: Injection
Status: Current. Reason: not specified. Form: Injection
Status: Current. Reason: not specified. Form: Injection
Status: Current. Reason: not specified. Form: Injection
Status: Current. Reason: not specified. Form: Injection
Vanilla Bourbon Trail Mix
Items: 7.01, 9.01
Items: 5.02, 7.01, 9.01
Items: 1.01, 8.01, 9.01
Items: 7.01, 8.01, 9.01
Items: 5.02, 9.01
Items: 5.02, 9.01
Items: 1.02
Items: 8.01
Items: 8.01
Items: 2.02, 7.01, 9.01
Items: 5.02
Items: 5.02, 5.07, 9.01
Items: 7.01, 8.01, 9.01
Items: 5.02, 7.01, 9.01
Items: 2.02, 9.01
Items: 8.01
Items: 7.01, 9.01
Items: 1.01, 7.01, 8.01, 9.01
Items: 5.02, 7.01, 9.01
Items: 7.01, 9.01
Items: 1.02, 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 9.01
Therapy area: Infectious Disease, Respiratory. Indication: Asthma, Influenzavirus A Infections, Influenzavirus B Infections
Therapy area: Gastrointestinal, Infectious Disease, Oncology. Indication: Acral Lentiginous Melanoma, Adenocarcinoma Of The Gastroesophageal Junction, Adenoid Cystic Carcinoma (ACC), Adrenocortical Carcinoma (Adrenal Cortex Cancer), Anaplastic Thyroid Cancer, Bile Duct Cancer (Cholangiocarcinoma), Bladder Cancer, Breast Cancer, Colorectal Cancer, Cutaneous Squamous Cell Carcinoma (cSCC), Endometrial Cancer, Ependymoma, Epithelial Ovarian Cancer, Esophageal Squamous Cell Carcinoma (ESCC), Ewing S